A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Mise à jour : Il y a 5 ans
Référence : NCT01473901

Femme et Homme

Extrait

This clinical study will assess the doses of BKM120 appropriate for patients with newly diagnosed glioblastoma when given in combination with radiotherapy and temozolomide.


Critère d'inclusion

  • Glioblastoma


Liens